Rui Xia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rui Xia has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Li Wu
Jiangsu Key Laboratory of Advanced Medical Analysis and Public Health, Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, No. 9, Seyuan Road, Nantong 226019, Jiangsu, P. R. China
3 shared publications - Yuling Qin
Jiangsu Key Laboratory of Advanced Medical Analysis and Public Health, Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, No. 9, Seyuan Road, Nantong 226019, Jiangsu, P. R. China
3 shared publications Shanmei Wang
Nantong University
2 shared publicationsXiabin Jing
State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China
2 shared publicationsXiaohui Wang
Nantong University
2 shared publicationsXinran Wang
Nantong University
2 shared publications
Latest Publications
- 22 December 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (9) , 2788-2799
Sulfur- or selenium-substituted Nile blue-based superoxide radical generators for precise photodynamic therapy and immunotherapy
Our research work and some related previous works were highlighted in the development of sulfur- or selenium-substituted Nile blue-based superoxide radical generator to facilitate the design of type I photosensitizers for precise photoimmunotherapy.
- 22 December 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (9) , 2788-2799
Sulfur- or selenium-substituted Nile blue-based superoxide radical generators for precise photodynamic therapy and immunotherapy
Our research work and some related previous works were highlighted in the development of sulfur- or selenium-substituted Nile blue-based superoxide radical generator to facilitate the design of type I photosensitizers for precise photoimmunotherapy.
- 12 December 2025
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 27 (1) , 580-595
Facile Preparation of Nanoscale Chlorin-Integrated Covalent Organic Frameworks for Combined Chemophototherapy
Covalent organic frameworks (COFs) offer structural tunability and intrinsic porosity, yet precise nanoscale fabrication of COF-based photosensitizers remains challenging. In this study, we report a mixed-solvent-mediated one-pot strategy to synthesize chlorin (TPC)-incorporated COF nanoparticles with tunable size by adjusting solvent composition and TPC feed ratio. Azo-based ligands confer hypoxia sensitivity to the framework. The optimized TPCCOF morphology was used to load tirapazamine (TPZ), forming the biocompatible TPCCOF@TPZ nanoplatform. Upon light irradiation, TPCCOF@TPZ enables concurrent photodynamic (PDT) and photothermal therapy (PTT). PDT exacerbates tumor hypoxia, triggering TPZ release and hypoxia-activated chemotherapy. This synergistic PDT/PTT/chemotherapy combination effectively suppresses 4T1 tumor cell proliferation under both normoxic and hypoxic conditions. Our work advances nanoscale COF design for multimodal cancer therapy and supports preclinical development of porphyrin-based photosensitizers.
- 12 December 2025
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 27 (1) , 580-595
Facile Preparation of Nanoscale Chlorin-Integrated Covalent Organic Frameworks for Combined Chemophototherapy
Covalent organic frameworks (COFs) offer structural tunability and intrinsic porosity, yet precise nanoscale fabrication of COF-based photosensitizers remains challenging. In this study, we report a mixed-solvent-mediated one-pot strategy to synthesize chlorin (TPC)-incorporated COF nanoparticles with tunable size by adjusting solvent composition and TPC feed ratio. Azo-based ligands confer hypoxia sensitivity to the framework. The optimized TPCCOF morphology was used to load tirapazamine (TPZ), forming the biocompatible TPCCOF@TPZ nanoplatform. Upon light irradiation, TPCCOF@TPZ enables concurrent photodynamic (PDT) and photothermal therapy (PTT). PDT exacerbates tumor hypoxia, triggering TPZ release and hypoxia-activated chemotherapy. This synergistic PDT/PTT/chemotherapy combination effectively suppresses 4T1 tumor cell proliferation under both normoxic and hypoxic conditions. Our work advances nanoscale COF design for multimodal cancer therapy and supports preclinical development of porphyrin-based photosensitizers.
- 9 September 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (80) , 15537-15560
Progress in porphyrin-based covalent organic frameworks for enhanced photodynamic antimicrobial therapy
Bacterial infections that delay wound healing represent a substantial challenge to human health. The advancement and implementation of porphyrin-based phototherapy provide a critical solution for addressing bacterial resistance, which has been exacerbated by the overuse of conventional antibiotics. However, the inherent hydrophobicity of porphyrin photosensitizers frequently results in aggregation and diminished photochemical performance. Porphyrin-based covalent organic frameworks (COFs) effectively resolve this issue by preventing aggregation and generating reactive oxygen species (ROS) as well as photothermal effects upon light irradiation, thereby suppressing bacterial proliferation. This review systematically summarizes recent progress in utilizing porphyrin-based COFs for the treatment of bacterial infections. It begins with a comprehensive analysis of how the physical structural characteristics of porphyrin-based COFs influence their photochemical efficiency, highlighting the strategies for enhancing the photochemical properties of COFs through rational structural engineering. Finally, the photodynamically combined antimicrobial therapy strategy based on porphyrin COFs was systematically summarized, with the aim of improving the inhibition of antibiotic-resistant bacteria, including Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). This focus highlights the significant potential of porphyrin-based COFs as effective antibacterial agents. The insights presented herein are intended to stimulate the development of advanced COF materials for combating bacterial infections and promoting wound healing, providing a promising avenue for future research and applications in the biomedical field.
- 9 September 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (80) , 15537-15560
Progress in porphyrin-based covalent organic frameworks for enhanced photodynamic antimicrobial therapy
Bacterial infections that delay wound healing represent a substantial challenge to human health. The advancement and implementation of porphyrin-based phototherapy provide a critical solution for addressing bacterial resistance, which has been exacerbated by the overuse of conventional antibiotics. However, the inherent hydrophobicity of porphyrin photosensitizers frequently results in aggregation and diminished photochemical performance. Porphyrin-based covalent organic frameworks (COFs) effectively resolve this issue by preventing aggregation and generating reactive oxygen species (ROS) as well as photothermal effects upon light irradiation, thereby suppressing bacterial proliferation. This review systematically summarizes recent progress in utilizing porphyrin-based COFs for the treatment of bacterial infections. It begins with a comprehensive analysis of how the physical structural characteristics of porphyrin-based COFs influence their photochemical efficiency, highlighting the strategies for enhancing the photochemical properties of COFs through rational structural engineering. Finally, the photodynamically combined antimicrobial therapy strategy based on porphyrin COFs was systematically summarized, with the aim of improving the inhibition of antibiotic-resistant bacteria, including Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). This focus highlights the significant potential of porphyrin-based COFs as effective antibacterial agents. The insights presented herein are intended to stimulate the development of advanced COF materials for combating bacterial infections and promoting wound healing, providing a promising avenue for future research and applications in the biomedical field.
- 6 November 2023
- Published by Elsevier in Microchemical Journal
- Vol. 196
Recent advances in sensing platforms based on metal/covalent organic framework for the detection of food-borne organic contaminants
- 6 November 2023
- Published by Elsevier in Microchemical Journal
- Vol. 196
Recent advances in sensing platforms based on metal/covalent organic framework for the detection of food-borne organic contaminants
- 30 October 2021
- Published by Royal Society of Chemistry (RSC) in Materials Chemistry Frontiers
- Vol. 5 (24) , 8333-8340
Nanoscale aggregates of porphyrins: red-shifted absorption, enhanced absorbance and phototherapeutic activity
Ordered porphyrin aggregates with red-shifted absorption and enhanced absorbance have been developed by screening molecular structures, solvents and surfactants.
- 30 October 2021
- Published by Royal Society of Chemistry (RSC) in Materials Chemistry Frontiers
- Vol. 5 (24) , 8333-8340
Nanoscale aggregates of porphyrins: red-shifted absorption, enhanced absorbance and phototherapeutic activity
Ordered porphyrin aggregates with red-shifted absorption and enhanced absorbance have been developed by screening molecular structures, solvents and surfactants.
- 27 August 2020
- Published by Wiley in Angewandte Chemie
- Vol. 132 (51) , 23398-23405
A Paclitaxel Prodrug Activatable by Irradiation in a Hypoxic Microenvironment
The innate hypoxic microenvironment of most solid tumors has a major influence on tumor growth, invasiveness, and distant metastasis. Here, a hypoxia‐activated self‐immolative prodrug of paclitaxel (PTX2‐Azo) was synthesized and encapsulated by a peptide copolymer decorated with the photosensitizer chlorin e6 (Ce6) to prepare light‐boosted PTX nanoparticle (Ce6/PTX2‐Azo NP). In this nanoparticle, PTX2‐Azo prevents premature drug leakage and realizes specific release in hypoxic tumor microenvironment and the photosensitizer Ce6 not only efficiently generates singlet oxygen under light irradiation but also acts as a positive amplifier to promote the release of PTX. The combination of photodynamic therapy (PDT) and chemotherapy results in excellent antitumor efficacy, demonstrating the great potential for synergistic cancer therapy.
- 27 August 2020
- Published by Wiley in Angewandte Chemie
- Vol. 132 (51) , 23398-23405
A Paclitaxel Prodrug Activatable by Irradiation in a Hypoxic Microenvironment
The innate hypoxic microenvironment of most solid tumors has a major influence on tumor growth, invasiveness, and distant metastasis. Here, a hypoxia‐activated self‐immolative prodrug of paclitaxel (PTX2‐Azo) was synthesized and encapsulated by a peptide copolymer decorated with the photosensitizer chlorin e6 (Ce6) to prepare light‐boosted PTX nanoparticle (Ce6/PTX2‐Azo NP). In this nanoparticle, PTX2‐Azo prevents premature drug leakage and realizes specific release in hypoxic tumor microenvironment and the photosensitizer Ce6 not only efficiently generates singlet oxygen under light irradiation but also acts as a positive amplifier to promote the release of PTX. The combination of photodynamic therapy (PDT) and chemotherapy results in excellent antitumor efficacy, demonstrating the great potential for synergistic cancer therapy.